Huashan Hospital
Clinical trials sponsored by Huashan Hospital, explained in plain language.
-
Could a common drug tame a rare brain artery disorder?
Disease control Not yet recruitingThis pilot trial tests whether sirolimus, an anti-inflammatory drug, can reduce artery wall swelling in people with vertebrobasilar dolichoectasia (VBD), a condition where arteries at the base of the brain become enlarged and twisted. Twelve participants will take sirolimus daily…
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common blood pressure drug tame a rare brain artery disorder?
Disease control Not yet recruitingThis pilot study tests whether amiloride, a drug used for high blood pressure, can reduce inflammation in the walls of enlarged arteries at the base of the brain in people with vertebrobasilar dolichoectasia (VBD). Six adults with VBD will take amiloride for up to 12 months. Rese…
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat brain autoimmune diseases
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called C-CAR168, which uses a patient's own immune cells modified to attack harmful cells in the body. It is for 15 adults with multiple sclerosis, neuromyelitis optica, autoimmune encephalitis, or stiff person syndrome that have …
Phase: PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New cocktail of drugs aims to tackle rare brain cancer
Disease control Not yet recruitingThis trial is testing whether adding a targeted drug called orelabrutinib to standard chemotherapy can improve outcomes for people newly diagnosed with primary central nervous system lymphoma, a rare type of brain cancer. About 215 participants will be randomly assigned to one of…
Phase: PHASE2, PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
23,000 seniors join study to unlock secrets of aging and infection
Knowledge-focused Not yet recruitingThis research project aims to understand why older adults get more infections and why those infections can be more serious. By following 23,000 people aged 60 and older, scientists will collect health data and samples like blood and stool to study how the immune system changes wi…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
AI could cut wait times for blood test results in major study
Knowledge-focused Not yet recruitingThis study will test whether an artificial intelligence (AI) tool can help doctors review complete blood count (CBC) results faster than the current manual process. About 20,000 people who already need a routine blood test will have their results analyzed by the AI, with no extra…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
AI could revolutionize TB care by predicting who needs shorter treatment
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to analyze data from over 31,000 tuberculosis patients. The goal is to create a system that helps doctors decide which patients can be cured with a short treatment course and which need longer therapy. The AI will be tested to see if it…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Hand sanitizer location may impact patient trust, study finds
Knowledge-focused Not yet recruitingThis study looks at whether the placement of hand sanitizer in a doctor's office affects how much psoriasis patients trust their doctor and feel stigmatized. Researchers will observe doctors' hand hygiene habits and ask 250 patients to fill out questionnaires. The goal is to find…
Phase: NA • Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New scan may reveal brain tumor drug effects in weeks, not years
Knowledge-focused Not yet recruitingThis study looks at whether a special PET scan (18F-AGX) can detect early changes in brain tumor activity in adults with slow-growing IDH-mutant gliomas who are taking the drug Vorasidenib. Ten participants will get the drug daily for about a year and have multiple PET and MRI sc…
Phase: NA • Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC